Corrigendum: Increased Toll-Like Receptors Activity and TLR Ligands in Patients with Autoimmune Thyroid Diseases

Front Immunol. 2017 May 15:8:551. doi: 10.3389/fimmu.2017.00551. eCollection 2017.

Shiqiao Peng¹, Chenyan Li^{1

2}, Xinyi Wang^{1

3}, Xin Liu^{1

4}, Cheng Han¹, Ting Jin^{1

5}, Shanshan Liu^{1

6}, Xiaowen Zhang¹, Hanyi Zhang¹, Xue He¹, Xiaochen Xie¹, Xiaohui Yu^{1

2}, Chuyuan Wang^{1

2}, Ling Shan¹, Chenling Fan¹, Zhongyan Shan^{1

2}, Weiping Teng^{1

2}

¹ Department of Endocrinology and Metabolism, Institute of Endocrinology, Liaoning Provincial Key Laboratory of Endocrine Diseases, The First Affiliated Hospital of China Medical University, China Medical University, Shenyang, Liaoning, China.
² Department of Endocrinology and Metabolism, The First Hospital of China Medical University, Shenyang, China.
³ Department of Laboratory Medicine, The First Hospital of China Medical University, Shenyang, China.
⁴ Department of Intensive Care Unit, Affiliated Hospital of Qingdao University, Qingdao, China.
⁵ Department of Endocrinology, Sir Run Run Shaw Hospital, Affiliated to School of Medicine, Zhejiang University, Hangzhou, China.
⁶ Department of Emergency, People's Liberation Army No.202 Hospital, Shenyang, China.

Abstract

[This corrects the article on p. 578 in vol. 7, PMID: 28018345.].

Keywords: autoimmune thyroid disease; innate immunity; pathogenesis; signaling; toll-like receptor.